Syneron Medical Ltd
ELOS
ELOS was delisted on the 14th of July, 2017.
79 hedge funds and large institutions have $235M invested in Syneron Medical Ltd in 2017 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 14 increasing their positions, 22 reducing their positions, and 44 closing their positions.
9% less capital invested
Capital invested by funds: $257M → $235M (-$22.5M)
13% less funds holding
Funds holding: 91 → 79 (-12)
27% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 44
36% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 22
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GLAM
Gardner Lewis Asset Management
Chadds Ford,
Pennsylvania
|
+$18M |
| 2 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$16.2M |
| 3 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$12.1M |
| 4 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$9.66M |
| 5 |
SG Americas Securities
New York
|
+$5.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTC
North Tide Capital
Boston,
Massachusetts
|
-$31.6M |
| 2 |
SM
Senvest Management
New York
|
-$23.2M |
| 3 |
DGI
Discovery Group I
Chicago,
Illinois
|
-$12.9M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$12.1M |
| 5 |
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
|
-$8.39M |
ELOS Hedge Fund Activity: Q2 2017 in Review
79 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q2 2017, worth a combined $235M — down 8.7% from $257M a quarter earlier.
Sellers outnumbered buyers: 44 funds closed out of ELOS and 32 opened new positions — a net loss of 12 holders — while 22 trimmed existing stakes and 14 added.
The largest buyer was Gardner Lewis Asset Management, opening a new position worth an estimated $18M. The largest seller was North Tide Capital, exiting entirely with an estimated $31.6M sold.
- 79 institutional investors held Syneron Medical Ltd (ELOS) as of Q2 2017, down from 91 in Q1 2017.
- Funds reported $235M of Syneron Medical Ltd stock for Q2 2017, down 8.7% quarter-over-quarter.
- 32 funds opened new Syneron Medical Ltd positions in Q2 2017 and 44 closed out, a net change of -12 holders.
- The largest Syneron Medical Ltd buyer in Q2 2017 was Gardner Lewis Asset Management, an estimated $18M added.
- The largest Syneron Medical Ltd seller in Q2 2017 was North Tide Capital, an estimated $31.6M sold.
Based on aggregated 13F filings for Q2 2017.